Joyce Anne Regalado, Mariel Mae Tayam, R. Santos, January E. Gelera
{"title":"自我报告嗅觉丧失的新冠肺炎患者嗅觉障碍患病率与客观嗅觉测试的比较:系统评价和Meta-Analysis","authors":"Joyce Anne Regalado, Mariel Mae Tayam, R. Santos, January E. Gelera","doi":"10.32412/PJOHNS.V36I1.1649","DOIUrl":null,"url":null,"abstract":"Background: Olfactory dysfunction (OD) in COVID-19 presents as a sudden onset smell loss commonly seen in mild symptomatic cases with or without rhinitis but can occur as an isolated symptom. The reported prevalence of OD among COVID-19 patients ranged from 5% to 98%. Although numerous studies have been conducted about their association, these were mainly based on self-reported cases and subjective questionnaires. Objective: This study investigates whether there is a significant difference in the prevalence of olfactory dysfunction between self-reported and objective testing using validated objective olfactory tests among RT-PCR confirmed COVID-19 patients. Methods: PubMed (MEDLINE), Cochrane, Web of Science, and Google Scholar were searched for studies investigating the prevalence of OD by using objective olfactory tests among patients who self-reported OD (November 1, 2019 to July 31, 2020). All studies were assessed for quality and bias using the Cochrane bias tool. Patient demographics, type of objective olfactory test, and results of self-reported OD and objective testing were reported. Results: Nine studies encompassing 673 patients met the inclusion criteria. Validated objective olfactory tests used in the included studies were CCCRC, SST and SIT. Overall prevalence of OD among patients who self-reported was higher after objective testing (71% versus 81%). This was also seen in when we performed subgroup analysis based on the objective tests that were used. However, meta-analysis using random effects model showed no significant difference in the overall prevalence of OD (p-value=.479, 95% CI 56.6 to 84.0 versus 71.2 to 89.8) as well as in the subgroups. Conclusion: To the best of our knowledge, this is the first meta-analysis that statistically reviewed articles that evaluated the difference between self-reported and objective tests done on the same patients. Results showing that self-reporting OD approximates the results of the objective tests among COVID-19 positive patients may imply that self-reporting can be sufficient in contact tracing and triggering swabbing and self-quarantine during the time of COVID-19 and objective Prevalence of Olfactory Dysfunction Among COVID-19 Patients with Self-Reported Smell Loss Versus Objective Olfactory Tests: A Systematic Review and Meta-Analysis Joyce Anne F. Regalado, MD Mariel Mae H. Tayam, MD Romiena A. Santos, MD January E. Gelera, MD Department of Otorhinolaryngology Head and Neck Surgery ‘Amang’ Rodriguez Memorial Medical Center Correspondence: Dr. January E. Gelera Department of Otorhinolaryngology Head and Neck Surgery ‘Amang’ Rodriguez Memorial Medical Center Sumulong Highway, Sto. Niño, Marikina City 1800 Philippines Phone: +63 915 490 4673 Email: januarygelera@gmail.com The authors declared that this represents original material that is not being considered for publication or has not been published or accepted for publication elsewhere in full or in part, in print or electronic media; that the requirements for authorship have been met by all the authors, and that each author believes that the manuscript represents honest work. Disclosures: The authors signed a disclosure that there are no financial or other (including personal) relationships, intellectual passion, political or religious beliefs, and institutional affiliations that might lead to a conflict of interest. Funding: No funding support was received for this study. Presented at the Philippine Society of Otolaryngology Head and Neck Surgery COVID-19 Research Forum 2020 (1st Place). November 18, 2020. Philipp J Otolaryngol Head Neck Surg 2021; 36 (1): 6-14 c Philippine Society of Otolaryngology – Head and Neck Surgery, Inc. Creative Commons (CC BY-NC-ND 4.0) Attribution NonCommercial NoDerivatives 4.0 International PhiliPPine Journal of otolaryngology-head and neck Surgery Vol. 36 no. 1 January – June 2021 PhiliPPine Journal of otolaryngology-head and neck Surgery Vol. 36 no. 1 January – June 2021 PhiliPPine Journal of otolaryngology-head and neck Surgery 7 6 PhiliPPine Journal of otolaryngology-head and neck Surgery REVIEW ARTICLE tests can be used as an adjunct in the diagnosis particularly in research. However, this study was limited by small sample size and articles done in European countries hence, interpretation and application of the results of this study must be approached with care. Further studies documenting the difference between self-reporting and objective test in large scale setting involving different countries may be helpful in establishing a definitive consensus. Registration: PROSPERO ID CRD42020204063","PeriodicalId":33358,"journal":{"name":"Philippine Journal of Otolaryngology Head and Neck Surgery","volume":"36 1","pages":"6"},"PeriodicalIF":0.0000,"publicationDate":"2021-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Prevalence of Olfactory Dysfunction Among COVID-19 Patients with Self-Reported Smell Loss Versus Objective Olfactory Tests: A Systematic Review and Meta-Analysis\",\"authors\":\"Joyce Anne Regalado, Mariel Mae Tayam, R. Santos, January E. Gelera\",\"doi\":\"10.32412/PJOHNS.V36I1.1649\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: Olfactory dysfunction (OD) in COVID-19 presents as a sudden onset smell loss commonly seen in mild symptomatic cases with or without rhinitis but can occur as an isolated symptom. The reported prevalence of OD among COVID-19 patients ranged from 5% to 98%. Although numerous studies have been conducted about their association, these were mainly based on self-reported cases and subjective questionnaires. Objective: This study investigates whether there is a significant difference in the prevalence of olfactory dysfunction between self-reported and objective testing using validated objective olfactory tests among RT-PCR confirmed COVID-19 patients. Methods: PubMed (MEDLINE), Cochrane, Web of Science, and Google Scholar were searched for studies investigating the prevalence of OD by using objective olfactory tests among patients who self-reported OD (November 1, 2019 to July 31, 2020). All studies were assessed for quality and bias using the Cochrane bias tool. Patient demographics, type of objective olfactory test, and results of self-reported OD and objective testing were reported. Results: Nine studies encompassing 673 patients met the inclusion criteria. Validated objective olfactory tests used in the included studies were CCCRC, SST and SIT. Overall prevalence of OD among patients who self-reported was higher after objective testing (71% versus 81%). This was also seen in when we performed subgroup analysis based on the objective tests that were used. However, meta-analysis using random effects model showed no significant difference in the overall prevalence of OD (p-value=.479, 95% CI 56.6 to 84.0 versus 71.2 to 89.8) as well as in the subgroups. Conclusion: To the best of our knowledge, this is the first meta-analysis that statistically reviewed articles that evaluated the difference between self-reported and objective tests done on the same patients. Results showing that self-reporting OD approximates the results of the objective tests among COVID-19 positive patients may imply that self-reporting can be sufficient in contact tracing and triggering swabbing and self-quarantine during the time of COVID-19 and objective Prevalence of Olfactory Dysfunction Among COVID-19 Patients with Self-Reported Smell Loss Versus Objective Olfactory Tests: A Systematic Review and Meta-Analysis Joyce Anne F. Regalado, MD Mariel Mae H. Tayam, MD Romiena A. Santos, MD January E. Gelera, MD Department of Otorhinolaryngology Head and Neck Surgery ‘Amang’ Rodriguez Memorial Medical Center Correspondence: Dr. January E. Gelera Department of Otorhinolaryngology Head and Neck Surgery ‘Amang’ Rodriguez Memorial Medical Center Sumulong Highway, Sto. Niño, Marikina City 1800 Philippines Phone: +63 915 490 4673 Email: januarygelera@gmail.com The authors declared that this represents original material that is not being considered for publication or has not been published or accepted for publication elsewhere in full or in part, in print or electronic media; that the requirements for authorship have been met by all the authors, and that each author believes that the manuscript represents honest work. Disclosures: The authors signed a disclosure that there are no financial or other (including personal) relationships, intellectual passion, political or religious beliefs, and institutional affiliations that might lead to a conflict of interest. Funding: No funding support was received for this study. Presented at the Philippine Society of Otolaryngology Head and Neck Surgery COVID-19 Research Forum 2020 (1st Place). November 18, 2020. Philipp J Otolaryngol Head Neck Surg 2021; 36 (1): 6-14 c Philippine Society of Otolaryngology – Head and Neck Surgery, Inc. Creative Commons (CC BY-NC-ND 4.0) Attribution NonCommercial NoDerivatives 4.0 International PhiliPPine Journal of otolaryngology-head and neck Surgery Vol. 36 no. 1 January – June 2021 PhiliPPine Journal of otolaryngology-head and neck Surgery Vol. 36 no. 1 January – June 2021 PhiliPPine Journal of otolaryngology-head and neck Surgery 7 6 PhiliPPine Journal of otolaryngology-head and neck Surgery REVIEW ARTICLE tests can be used as an adjunct in the diagnosis particularly in research. However, this study was limited by small sample size and articles done in European countries hence, interpretation and application of the results of this study must be approached with care. Further studies documenting the difference between self-reporting and objective test in large scale setting involving different countries may be helpful in establishing a definitive consensus. Registration: PROSPERO ID CRD42020204063\",\"PeriodicalId\":33358,\"journal\":{\"name\":\"Philippine Journal of Otolaryngology Head and Neck Surgery\",\"volume\":\"36 1\",\"pages\":\"6\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-05-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Philippine Journal of Otolaryngology Head and Neck Surgery\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.32412/PJOHNS.V36I1.1649\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Philippine Journal of Otolaryngology Head and Neck Surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.32412/PJOHNS.V36I1.1649","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
摘要
背景:新冠肺炎的嗅觉功能障碍(OD)表现为突发性嗅觉丧失,常见于伴有或不伴有鼻炎的轻度症状病例,但也可作为孤立症状出现。据报道,新冠肺炎患者的OD患病率在5%至98%之间。尽管已经对它们的关联进行了大量研究,但这些研究主要基于自我报告的案例和主观问卷。目的:本研究调查在RT-PCR确诊的新冠肺炎患者中,使用经验证的客观嗅觉测试进行自我报告和客观测试之间,嗅觉功能障碍的患病率是否存在显著差异。方法:检索PubMed(MEDLINE)、Cochrane、Web of Science和Google Scholar,通过客观嗅觉测试调查自我报告OD患者(2019年11月1日至2020年7月31日)的OD患病率。使用Cochrane偏倚工具评估所有研究的质量和偏倚。报告了患者人口统计学、客观嗅觉测试类型以及自我报告的OD和客观测试结果。结果:包括673名患者的9项研究符合纳入标准。纳入研究中使用的经验证的客观嗅觉测试为CCCRC、SST和SIT。客观测试后,自我报告的患者OD的总体患病率较高(71%对81%)。当我们根据所使用的客观测试进行亚组分析时,也可以看到这一点。然而,使用随机效应模型的荟萃分析显示,OD的总体患病率和亚组之间没有显著差异(p值=.479,95%CI 56.6至84.0,而71.2至89.8)。结论:据我们所知,这是第一个对评估对同一患者进行的自我报告和客观测试之间差异的文章进行统计审查的荟萃分析。结果表明,自我报告OD接近新冠肺炎阳性患者的客观测试结果,这可能意味着自我报告足以追踪接触者,并在新冠肺炎期间触发拭子和自我隔离,以及自我报告嗅觉丧失的新冠肺炎患者的客观嗅觉障碍患病率与客观嗅觉障碍测试:A系统回顾和荟萃分析Joyce Anne F.Regalado,医学博士Mariel Mae H.Tayam,医学博士Romiena A.Santos,医学博士January E.Gelera,耳鼻咽喉头颈外科医学博士“Amang”Rodriguez纪念医疗中心通信:Dr.January E.Gelera耳鼻咽喉咽喉头颈外科“Amang’Rodrigues纪念医疗中心,Sto Sumulong Highway。菲律宾马里基纳市Niño 1800电话:+63 915 490 4673电子邮件:januarygelera@gmail.com提交人声明,这是未考虑出版的原始材料,或未在印刷或电子媒体上全部或部分在其他地方出版或接受出版的原始资料;所有作者都满足了作者身份的要求,每个作者都认为手稿代表了诚实的作品。披露:作者签署了一份披露,称不存在可能导致利益冲突的财务或其他(包括个人)关系、智力激情、政治或宗教信仰以及机构关系。资金:本研究未收到任何资金支持。在2020年菲律宾耳鼻咽喉头颈外科学会新冠肺炎研究论坛上发表(第一名)。2020年11月18日。菲利普耳鼻咽喉头颈外科杂志2021;36(1):6-14 c菲律宾耳鼻咽喉学会-头颈外科,股份有限公司。知识共享(CC BY-NC-ND 4.0)归因非商业性NoDerivatives 4.0国际费城耳鼻喉科头颈外科杂志第36卷第1期2021年1月至6月费城耳鼻咽喉科头颈外科期刊第36卷第一期2021年1-6月费城耳喉科头颈科杂志第7 6期外科综述文章测试可以作为诊断的辅助手段,尤其是在研究中。然而,这项研究受到样本量小和在欧洲国家发表的文章的限制,因此,必须谨慎解读和应用这项研究的结果。进一步研究记录在涉及不同国家的大规模环境中自我报告和客观测试之间的差异,可能有助于建立最终共识。注册:PROSPERO ID CRD42020204063
Prevalence of Olfactory Dysfunction Among COVID-19 Patients with Self-Reported Smell Loss Versus Objective Olfactory Tests: A Systematic Review and Meta-Analysis
Background: Olfactory dysfunction (OD) in COVID-19 presents as a sudden onset smell loss commonly seen in mild symptomatic cases with or without rhinitis but can occur as an isolated symptom. The reported prevalence of OD among COVID-19 patients ranged from 5% to 98%. Although numerous studies have been conducted about their association, these were mainly based on self-reported cases and subjective questionnaires. Objective: This study investigates whether there is a significant difference in the prevalence of olfactory dysfunction between self-reported and objective testing using validated objective olfactory tests among RT-PCR confirmed COVID-19 patients. Methods: PubMed (MEDLINE), Cochrane, Web of Science, and Google Scholar were searched for studies investigating the prevalence of OD by using objective olfactory tests among patients who self-reported OD (November 1, 2019 to July 31, 2020). All studies were assessed for quality and bias using the Cochrane bias tool. Patient demographics, type of objective olfactory test, and results of self-reported OD and objective testing were reported. Results: Nine studies encompassing 673 patients met the inclusion criteria. Validated objective olfactory tests used in the included studies were CCCRC, SST and SIT. Overall prevalence of OD among patients who self-reported was higher after objective testing (71% versus 81%). This was also seen in when we performed subgroup analysis based on the objective tests that were used. However, meta-analysis using random effects model showed no significant difference in the overall prevalence of OD (p-value=.479, 95% CI 56.6 to 84.0 versus 71.2 to 89.8) as well as in the subgroups. Conclusion: To the best of our knowledge, this is the first meta-analysis that statistically reviewed articles that evaluated the difference between self-reported and objective tests done on the same patients. Results showing that self-reporting OD approximates the results of the objective tests among COVID-19 positive patients may imply that self-reporting can be sufficient in contact tracing and triggering swabbing and self-quarantine during the time of COVID-19 and objective Prevalence of Olfactory Dysfunction Among COVID-19 Patients with Self-Reported Smell Loss Versus Objective Olfactory Tests: A Systematic Review and Meta-Analysis Joyce Anne F. Regalado, MD Mariel Mae H. Tayam, MD Romiena A. Santos, MD January E. Gelera, MD Department of Otorhinolaryngology Head and Neck Surgery ‘Amang’ Rodriguez Memorial Medical Center Correspondence: Dr. January E. Gelera Department of Otorhinolaryngology Head and Neck Surgery ‘Amang’ Rodriguez Memorial Medical Center Sumulong Highway, Sto. Niño, Marikina City 1800 Philippines Phone: +63 915 490 4673 Email: januarygelera@gmail.com The authors declared that this represents original material that is not being considered for publication or has not been published or accepted for publication elsewhere in full or in part, in print or electronic media; that the requirements for authorship have been met by all the authors, and that each author believes that the manuscript represents honest work. Disclosures: The authors signed a disclosure that there are no financial or other (including personal) relationships, intellectual passion, political or religious beliefs, and institutional affiliations that might lead to a conflict of interest. Funding: No funding support was received for this study. Presented at the Philippine Society of Otolaryngology Head and Neck Surgery COVID-19 Research Forum 2020 (1st Place). November 18, 2020. Philipp J Otolaryngol Head Neck Surg 2021; 36 (1): 6-14 c Philippine Society of Otolaryngology – Head and Neck Surgery, Inc. Creative Commons (CC BY-NC-ND 4.0) Attribution NonCommercial NoDerivatives 4.0 International PhiliPPine Journal of otolaryngology-head and neck Surgery Vol. 36 no. 1 January – June 2021 PhiliPPine Journal of otolaryngology-head and neck Surgery Vol. 36 no. 1 January – June 2021 PhiliPPine Journal of otolaryngology-head and neck Surgery 7 6 PhiliPPine Journal of otolaryngology-head and neck Surgery REVIEW ARTICLE tests can be used as an adjunct in the diagnosis particularly in research. However, this study was limited by small sample size and articles done in European countries hence, interpretation and application of the results of this study must be approached with care. Further studies documenting the difference between self-reporting and objective test in large scale setting involving different countries may be helpful in establishing a definitive consensus. Registration: PROSPERO ID CRD42020204063